ONCOLife Articles
How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment
27 November 2024
FDA Greenlights Revumenib for Relapsed Leukemia Treatment
23 November 2024
How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment
ONCOLife | 21 November 2024
FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy
ONCOLife | 9 November 2024
Overcoming Resistance in Cancer Treatment with Cytokine Therapies
ONCOLife | 8 November 2024
Transforming Melanoma Treatment with DNA Plasmid Vaccine
ONCOLife | 28 October 2024
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
FDA & EMA
19 October 2024
FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer
ONCOLife
12 October 2024
Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries
Biotech
11 October 2024
Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform
ONCOLife
9 October 2024
The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment
ONCOLife
9 October 2024
The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC
ONCOLife
7 October 2024
ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer
Clinical Trials
17 September 2024
ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5%
Clinical Trials
16 September 2024
The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer
ONCOLife
12 September 2024
First Lung Cancer Vaccine Trial for BioNTech's BNT116 Launched Across 7 Countries
ONCOLife
25 August 2024
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.